Myeloid ACAT1/SOAT1: a novel regulator of dyslipidemia and retinal neovascularization

npj Metabolic Health and Disease · Published 2025-01-13 · DOI 10.1038/s44324-024-00046-x

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1038/s44324-024-00046-x

Abstract

Abstract Pathological retinal neovascularization (RNV) is a major cause of vision loss and blindness during ischemic retinopathies. Our investigations in the mouse model of oxygen-induced retinopathy (OIR) demonstrate a novel mechanism of pathological RNV and neurovascular injury. We show that OIR-induced activation of macrophage/microglial cells, retinal inflammation, and pathological RNV are mediated by increases in cholesterol ester (CE) formation due to activation of the acyl-CoA: Cholesterol Acyltransferase 1/Sterol O-Acyltransferase 1 (ACAT1/SOAT1) enzyme.

Abstract from DOAJ. Public domain (CC0 1.0).

Read the article at the publisher →

Publication details

Year
2025

Related articles